NIPC Law

Human Respiratory Syncytial Virus Author NIAID   Licence CC BY 2.0   Source    Wikimedia Commons   Jane Lambert Patents Court (Mr Justice Mellor)  Pfizer Ltd v GlaxoSmithKline Biologicals SA and another 2024] EWHC 2523 (Pat) (07 Oct 202 4) Pfizer Ltd v GlaxoSmithKline Biologicals SA and anothe r [2025] EWHC 52 (Pat) (16 Jan 2025) This was a claim by Pfizer Ltd. ("Pfizer")  for the revocation of  EP (UK) 3 109 258 ("258") and EP (UK) 2 222 710 ("710")  under s.72 (1) (a)  of the Patents Act 1977 on the grounds that the inventions for which those patents were granted were not patentable.  The patents were held by  GlaxoSmithKline Biologicals SA  and  ID Biomedical Corporation of Quebec  (collectively "GSK").   The reason for the litigation was that both Pfizer and GSK had developed vaccines for respiratory syncytial virus ("RSV")  that were about to receive marketing approval in the UK....

  Author  Ciencias Españolas   Licence  CC BY-SA 3.0   Source  Wikipedia Commons   Jane Lambert Patents Court (Michael Tappin KC sitting as a judge of the High Court) Hill v Touchlight Genetics Ltd and others [2025] EWHC 107 (Pat) (27 Jan 2025) I previously discussed this litigation in  Patents - Hill v Touchlight Genetics Ltd . on 11 July 2024.  I noted that it was an entitlement action, that is to say, a claim to ownership of certain patents and patent applications.   It was also an infringement claim in that the claimant alleged that the defendants had infringed the patents that she claimed. There was also a contingent counterclaim.  The action came before Michael Tappin KC sitting as a deputy judge of the High Court between 25 and 28 Nov 2024 and 3 to 4 and 10 to 11 Dec 2024.   At para [331] of his judgment in  Hill v Touchlight Genetics Ltd and others   [2025] EWHC 107 (Pat), which he handed down...